FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

ARKBArk 21Shares Bitcoin ETF

Inspect →

ARKOARKO Corp.

Inspect →

ARKRARK RESTAURANTS CORP

Inspect →

ARLAMERICAN REALTY INVESTORS INC

Inspect →

ARLOArlo Technologies, Inc.

Inspect →

ARLPALLIANCE RESOURCE PARTNERS LP

Inspect →

ARLSFARGO GRAPHENE SOLUTIONS CORP.

Inspect →

ARMARM HOLDINGS PLC /UK

Inspect →

ARMKAramark

Inspect →

ARMPArmata Pharmaceuticals, Inc.

Inspect →

ARNNYASR Nederland N.V./ADR

Inspect →

AROCArchrock, Inc.

Inspect →

03 / FINANCIAL CHANGES

Envista Holdings Corp NVST

Dental Equipment & Supplies · SIC 3843

Full analysis →

Latest standalone quarter

Period ending 2026-10-02

Filed: 2026-11-04 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2025-09-26.

Revenue691.50

USD million

Change year over year: +21.60 · +3.2%

Net income508.30

USD million

Change year over year: +538.60

Operating cash flow77.90

USD million

Change year over year: -0.80

Total liabilities—

USD million

No comparable prior-year value

Total assets5,611.00

USD million

Change year over year: -31.50

Liabilities / assets: —

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-02-12 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2024-12-31.

Revenue2,719.50

USD million

Change year over year: +208.90 · +8.3%

Net income47.00

USD million

Change year over year: +1,165.60

Operating cash flow275.70

USD million

Change year over year: -60.80

Total liabilities—

USD million

No comparable prior-year value

Total assets5,679.00

USD million

Change year over year: +328.50

Liabilities / assets: —

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
SONX ↗	2024-12-31	31.70	-88.4%	-77.8%
DROR ↗	2025-12-31	—	—	—
XRAY ↗	2025-12-31	3,680.00	-16.3%	6.4%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

FTCI ↗

FTC Solar, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RSVR ↗

Reservoir Media, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

CLNN ↗

Clene Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RLAY ↗

Relay Therapeutics, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

TPL ↗

Texas Pacific Land Corp

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

NUVB ↗

Nuvation Bio Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

DSGN ↗

Design Therapeutics, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

OZ ↗

Belpointe PREP, LLC

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

LYEL ↗

Lyell Immunopharma, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

ADEA ↗

Adeia Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RPRX ↗

Royalty Pharma plc

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

HRMY ↗

Harmony Biosciences Holdings, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →